KARLA BURNETT: Open Payments
NPI 1689129470 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 19 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $244 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $223 |
| Novo Nordisk Inc | 2 | $126 |
| ABBVIE INC. | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 1 | $30 |
| Dexcom, Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $21 |
| SHIELD THERAPEUTICS INC | 1 | $18 |
Products named: Ozempic, AIRSUPRA, FARXIGA, VOQUEZNA, Dexcom G6 Transmitter, LINZESS, FREESTYLE LIBRE 3, BREZTRI.
Industry payments across MS — which companies pay providers there.
